Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-25 @ 9:21 PM
NCT ID: NCT00131456
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00131456
Study Brief: Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Matched Placebo None None 0 52 24 52 View
Venlafaxine Venlafaxine: VEN-XR was titrated to the target dose of 225 mg/day (or the maximum tolerated dose) over the three weeks after randomization. After the fourth week post-randomization, patients with persistent depression who were not rated as having a CGI-Depression score of 1 ("very much improved') and who were tolerating 225 mg/day had their dose increased to a maximum of 375 mg/day. None None 0 51 33 51 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders None View
diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
dizziness SYSTEMATIC_ASSESSMENT General disorders None View
fatigue SYSTEMATIC_ASSESSMENT General disorders None View
GI Upset SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
headache SYSTEMATIC_ASSESSMENT General disorders None View
insomnia SYSTEMATIC_ASSESSMENT General disorders None View
loss of libido SYSTEMATIC_ASSESSMENT General disorders None View
muscle aches SYSTEMATIC_ASSESSMENT General disorders None View
nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
syncopy or light headedness SYSTEMATIC_ASSESSMENT General disorders None View